Kosuke Oishi

Suggest Changes
Learn More
BACKGROUND Aromatase inhibitors(AIs)are frequently employed for advanced or metastatic postmenopausal breast cancer as first-line hormone therapy. However, it is unknown which hormonal agent is the(More)